Efficacy of Different Treatments for the Intensive Care Unit Acquired Weakness
Efficacy of Conventional Rehabilitation, Transcutaneous Electro Nerve Stimulation or Early Mobilization to Reverse the Acquired Weakness of the Intensive Care Unit: Single Blind Controlled Clinical Trial
1 other identifier
interventional
18
0 countries
N/A
Brief Summary
Experimental study that has how to compare the efficacy between conventional rehabilitation, transcutaneous electrostimulation or early mobilization to reduce the time needed to reverse the muscle weakness evaluated by the muscle strength scale of the MRC in patients with a clinical diagnosis of intensive care unit acquired weakness in the (ICUAW).The ambit of realization is a medical-surgical ICU of a general acute hospital (26 beds). A randomized controlled, uni-centric design was used. The interventions are divided into three groups namely; group 1 (control group) receiving standard or usual rehabilitation (GR-STD); group 2 receives transcutaneous electrostimulation (GR-TEE) and group 3 that consists of an early mobilization protocol (GR-EM). The main outcome variable of the study is the time, in days and sessions of treatment, to reverse the ICUAW.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2015
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2016
CompletedFirst Submitted
Initial submission to the registry
June 21, 2018
CompletedFirst Posted
Study publicly available on registry
November 3, 2020
CompletedNovember 3, 2020
October 1, 2020
1.1 years
June 21, 2018
October 31, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
days needs to revert ICUAW
Number of days until reaching a value of the MRC-mss ≥ 48 points.
3 months
Sessions needs to revert ICUAW
Number of sessions until reaching a value of the MRC-mss ≥ 48 points.
3 months
Study Arms (3)
standard care or usual rehabilitation
ACTIVE COMPARATORIt will consist of the usual treatment performed by the intensive care physiotherapist, it will be applied every day that the study lasts.
neuro muscular electro stimulation
EXPERIMENTALThey received 5 sessions per week (except weekends) of neuromuscular electrostimulation of 30 minutes duration. Also, every day that the study is carried out in the morning and in the afternoon, the subjects will receive the usual treatment performed by the intensive care physiotherapist.
early mobilization protocol
EXPERIMENTALThroughout the duration of the study, an early mobilization protocol will be applied to apply a specific treatment based on different levels of treatment for each subject of the group; It differs from the usual procedure in protocolized progression according to the objectives reached by the patient, unlike the usual treatment, where the progression is in accordance with the clinical criteria of the treatment professional.
Interventions
We used a commercial equipment of electro stimulation with a pulse width of 300 micro seconds, a frequency of 50 Hz, with symmetrical balanced biphasic rectangular wave and with an intensity of up to 80 milliampere.
The protocol consisted in applying a specific treatment based on different levels of treatment to each subject. Admission to them was carried out according to the maximum capacity of each subject, the conditions of each level being the following: * Level 1: MRC (shoulder) \<3 + MRC \<3 (hip). * Level 2: MRC (shoulder) ≥ 3 + MRC (hip) \<3. * Level 3: MRC (shoulder) ≥ 3 + MRC (hip) ≥ 3 + sitting on the edge of the bed without assistance (minimum 15 minutes). * Level 4: Standing without assistance and walking with or without assistance.
routine, non-protocolized rehabilitation treatment performed by the physiotherapist assigned to intensive care
Eligibility Criteria
You may qualify if:
- subjects over 18 years of age,
- admitted to the ICU who have received invasive mechanical ventilation for a period longer than 24 hours
- clinical diagnosis of ICUAW (MRC-mss \<48 measured over two consecutive days).
You may not qualify if:
- subjects who presented a body mass index\> 35 (kg/height x height)
- presence of edema that prevents the realization of NMES at the time of diagnosis of ICUAW (assessed by the absence of visible contraction
- pregnant women
- subjects with pacemakers
- subjects with injury of the central and / or peripheral nervous system (with motor sequelae)
- previous neuromuscular disease
- limitation of the movement of any extremity due to orthopedic or traumatological causes
- presence of a previous cognitive disorder that impedes the understanding of rehabilitation interventions
- a value of the index of Barthel less than 35 points at admission
- subjets who refused to give informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ladislao P Diaz Ballve
Hospital Nacional Posadas
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- the person in charge of performing the statistical analysis was blind, by coding the interventions in the database.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 21, 2018
First Posted
November 3, 2020
Study Start
August 1, 2015
Primary Completion
August 31, 2016
Study Completion
August 31, 2016
Last Updated
November 3, 2020
Record last verified: 2020-10
Data Sharing
- IPD Sharing
- Will not share